Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

981

Participants

Timeline

Start Date

December 7, 2022

Primary Completion Date

November 12, 2025

Study Completion Date

May 8, 2026

Conditions
Chronic Hepatitis BHepatitis B, Chronic
Interventions
DRUG

Bepirovirsen

Bepirovirsen will be administered.

OTHER

Placebo

Matching placebo will be administered.

Trial Locations (177)

104

GSK Investigational Site, Taipei

333

GSK Investigational Site, Tau-Yuan

807

GSK Investigational Site, Kaohsiung City

833

GSK Investigational Site, Kaohsiung City

1061

GSK Investigational Site, Buenos Aires

1097

GSK Investigational Site, Budapest

1431

GSK Investigational Site, Sofia

1606

GSK Investigational Site, Sofia

3300

GSK Investigational Site, Eger

3530

GSK Investigational Site, Miskolc

5000

GSK Investigational Site, Veliko Tarnovo

5700

GSK Investigational Site, Gyula

10243

GSK Investigational Site, Berlin

10330

GSK Investigational Site, Bangkok

10439

GSK Investigational Site, Berlin

10676

GSK Investigational Site, Athens

10787

GSK Investigational Site, Berlin

11527

GSK Investigational Site, Athens

12163

GSK Investigational Site, Berlin

15355

GSK Investigational Site, Ansan

20122

GSK Investigational Site, Milan

20125

GSK Investigational Site, Bucharest

20162

GSK Investigational Site, Milan

21079

GSK Investigational Site, Dijon

21287

GSK Investigational Site, Baltimore

23219

GSK Investigational Site, Richmond

23249

GSK Investigational Site, Richmond

24080

GSK Investigational Site, León

25123

GSK Investigational Site, Brescia

26504

GSK Investigational Site, Rio Patras

28041

GSK Investigational Site, Madrid

29010

GSK Investigational Site, Málaga

31059

GSK Investigational Site, Toulouse

33134

GSK Investigational Site, Miami

33604

GSK Investigational Site, Pessac

35033

GSK Investigational Site, Rennes

36002

GSK Investigational Site, Vigo

37007

GSK Investigational Site, Salamanca

39008

GSK Investigational Site, Santander

40126

GSK Investigational Site, Modena

40225

GSK Investigational Site, Düsseldorf

40705

GSK Investigational Site, Taichung

42601

GSK Investigational Site, Daegu

44160

GSK Investigational Site, Guadalajara

44787

GSK Investigational Site, Bochum

46014

GSK Investigational Site, Valencia

47003

GSK Investigational Site, Valladolid

47392

GSK Investigational Site, Busan

48377

GSK Investigational Site, Detroit

50668

GSK Investigational Site, Cologne

52242

GSK Investigational Site, Iowa City

59037

GSK Investigational Site, Lille

63003

GSK Investigational Site, Clermont-Ferrand

67091

GSK Investigational Site, Strasbourg

68000

GSK Investigational Site, Oaxaca City

68100

GSK Investigational Site, Periohi Dragana Alexand

71100

GSK Investigational Site, Foggia

80100

GSK Investigational Site, Johor Bahru

80120

GSK Investigational Site, Littleton

80336

GSK Investigational Site, München

85224

GSK Investigational Site, Chandler

86021

GSK Investigational Site, Poitiers

90027

GSK Investigational Site, Los Angeles

92118

GSK Investigational Site, Clichy

94304

GSK Investigational Site, Palo Alto

95128

GSK Investigational Site, San Jose

95817

GSK Investigational Site, Davis

98124

GSK Investigational Site, Messina

100015

GSK Investigational Site, Beijing

100050

GSK Investigational Site, Beijing

110022

GSK Investigational Site, Shenyang

119074

GSK Investigational Site, Singapore

130021

GSK Investigational Site, Changchun

141001

GSK Investigational Site, Ludhiana

160012

GSK Investigational Site, Chandigarh

169608

GSK Investigational Site, Singapore

200025

GSK Investigational Site, Shanghai

200040

GSK Investigational Site, Shanghai

201506

GSK Investigational Site, Shanghai

210008

GSK Investigational Site, Nanjing

300001

GSK Investigational Site, Timișoara

302001

GSK Investigational Site, Jaipur

310000

GSK Investigational Site, Hangzhou

310003

GSK Investigational Site, Hangzhou

350025

GSK Investigational Site, Fuzhou

395002

GSK Investigational Site, Surat

400012

GSK Investigational Site, Mumbai

400026

GSK Investigational Site, Mumbai

400042

GSK Investigational Site, Chongqing

400162

GSK Investigational Site, Cluj-Napoca

411001

GSK Investigational Site, Pune

430022

GSK Investigational Site, Wuhan

450000

GSK Investigational Site, Zhengzhou

500033

GSK Investigational Site, Hyderabad

500048

GSK Investigational Site, HyderabadTelangana

510000

GSK Investigational Site, Guangzhou

510060

GSK Investigational Site, Guangzhou

510630

GSK Investigational Site, Guangzhou

518023

GSK Investigational Site, Shenzhen

576104

GSK Investigational Site, Manipal

590010

GSK Investigational Site, Belagavi

600113

GSK Investigational Site, Chennai

641005

GSK Investigational Site, Coimbatore

650021

GSK Investigational Site, Kunming

700116

GSK Investigational Site, Iași

710061

GSK Investigational Site, Xi'an

720224

GSK Investigational Site, Suceava

781006

GSK Investigational Site, Guhawati

830054

GSK Investigational Site, Ürümqi

90035003

GSK Investigational Site, Porto Alegre

C1061AAS

GSK Investigational Site, Buenos Aires

C1125ABE

GSK Investigational Site, Buenos Aires

C1181ACI

GSK Investigational Site, Capital Federal

B1629AHJ

GSK Investigational Site, Pilar

S2002KDT

GSK Investigational Site, Rosario

49060-010

GSK Investigational Site, Aracaju

13034-685

GSK Investigational Site, Campinas

80810-050

GSK Investigational Site, Curitiba

69040-000

GSK Investigational Site, Manaus

97105-900

GSK Investigational Site, Santa Maria

05403-000

GSK Investigational Site, São Paulo

08270-070

GSK Investigational Site, São Paulo

04121-000

GSK Investigational Site, Vila Mariana

Unknown

GSK Investigational Site, Sofia

GSK Investigational Site, Beijing

GSK Investigational Site, Chengdu

GSK Investigational Site, Zhenjiang

GSK Investigational Site, Kowloon

GSK Investigational Site, Pokfulam

GSK Investigational Site, Shatin

GSK Investigational Site, George Town

GSK Investigational Site, Kota Bharu Kelantan

GSK Investigational Site, Kota Kinabalu

GSK Investigational Site, Kuala Lumpur

GSK Investigational Site, Kuantan

V6Z 2K5

GSK Investigational Site, Vancouver

V8V 3M9

GSK Investigational Site, Victoria

K1H 8L6

GSK Investigational Site, Ottawa

M5G 2C4

GSK Investigational Site, Toronto

H2X 0A9

GSK Investigational Site, Montreal

H4A 3J1

GSK Investigational Site, Montreal

G1V 4G2

GSK Investigational Site, Québec

J7Z 2V4

GSK Investigational Site, Saint-Jérôme

400 008

GSK Investigational Site, Mumbai

272-8516

GSK Investigational Site, Chiba

790-8524

GSK Investigational Site, Ehime

820-8505

GSK Investigational Site, Fukuoka

839-0863

GSK Investigational Site, Fukuoka

500-8717

GSK Investigational Site, Gifu

503-8502

GSK Investigational Site, Gifu

734-8551

GSK Investigational Site, Hiroshima

737-0023

GSK Investigational Site, Hiroshima

053-8506

GSK Investigational Site, Hokkaido

660-8550

GSK Investigational Site, Hyōgo

862-8655

GSK Investigational Site, Kumamoto

980-8574

GSK Investigational Site, Miyagi

113-8519

GSK Investigational Site, Tokyo

173-8610

GSK Investigational Site, Tokyo

180-8610

GSK Investigational Site, Tokyo

07206

GSK Investigational Site, Panama City

41-902

GSK Investigational Site, Bytom

31-202

GSK Investigational Site, Krakow

37-100

GSK Investigational Site, Łańcut

021105

GSK Investigational Site, Bucharest

700-721

GSK Investigational Site, Daegu

03080

GSK Investigational Site, Seoul

06351

GSK Investigational Site, Seoul

07061

GSK Investigational Site, Seoul

08308

GSK Investigational Site, Seoul

08035

GSK Investigational Site, Barcelona

08036

GSK Investigational Site, Barcelona

06230

GSK Investigational Site, Ankara

B15 2TH

GSK Investigational Site, Birmingham

EH4 2XU

GSK Investigational Site, Edinburgh

LS9 7TF

GSK Investigational Site, Leeds West Yorkshire

SE5 9RS

GSK Investigational Site, London

SW17 0QT

GSK Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT05630807 - Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1) | Biotech Hunter | Biotech Hunter